The discussion highlights the importance of assessing atherosclerosis before initiating lipid-lowering therapy, particularly in individuals with high LDL cholesterol but low risk. If atherosclerosis is present, treatment urgency increases, but those with only fatty streaks may consider delaying medication. Monitoring progress over time can lead to a more tailored approach to treatment.
